慢性顽固性心力衰竭的发病特点与治疗效果观察

Observation on the Pathogenesis and Therapeutic Effect of Chronic Refractory Heart Failure

目的探讨慢性顽固性心力衰竭的发病特点与治疗效果。方法选择慢性顽固性心力衰竭症状患者700例作为入组成员,分别为对照组350例使用常规治疗,以及观察组350例使用人脑利钠肽(rhBNP)进行治疗,对患者最终所拥有的治疗成效进行比较与分析。结果观察组临床疗效高于对照组(P<0.05);观察组不良反应发生率低于对照组(P<0.05);观察组患者的LVEF水平明显高于对照组(P<0.05)。结论慢性顽固性心力衰竭的产生是因为心力衰竭症状得不到良好的缓解,因病情的恶化需要对患者实施长期的治疗与干预,临床现阶段对该症状的患者进行治疗的方式大多为药物治疗,有一定的治疗效果。

Objective To investigate and analyze the pathogenesis and treatment effect of chronic refractory heart failure.Methods A total of 700 patients with chronic refractory heart failure symptoms were selected as enrolled members,350 patients in the control group were treated with conventional treatment,and 350 patients in the observation group were treated with human brain natriuretic peptide(rhBNP).A comparison and analysis between the two groups was performed.Results The clinical efficacy of the observation group was higher than that of the control group(P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05).The level of LVEF in the observation group was significantly higher than that in the control group(P<0.05).Conclusion Chronic refractory heart failure occurs because the symptoms of heart failure cannot be well relieved,and long-term treatment and intervention are required for patients due to the deterioration of the condition.At the current clinical stage,most of the treatment methods for patients with this symptom are as follows:Drug treatment has a certain therapeutic effect.